Search Results - "Hamour, I."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    De Novo Donor HLA‐Specific Antibodies after Heart Transplantation Are an Independent Predictor of Poor Patient Survival by Smith, J. D., Banner, N. R., Hamour, I. M., Ozawa, M., Goh, A., Robinson, D., Terasaki, P. I., Rose, M. L.

    Published in American journal of transplantation (01-02-2011)
    “…Preformed donor HLA‐specific antibodies are a known indicator for poor patient survival after cardiac transplantation. The role of de novo donor‐specific…”
    Get full text
    Journal Article
  2. 2

    C4d Fixing, Luminex Binding Antibodies—A New Tool for Prediction of Graft Failure After Heart Transplantation by Smith, J. D., Hamour, I. M., Banner, N. R., Rose, M. L.

    Published in American journal of transplantation (01-12-2007)
    “…The standard method to detect pretransplant antibodies has been the complement dependent cytotoxicity (CDC) test of donor leukocytes. Solid phase assays to…”
    Get full text
    Journal Article
  3. 3

    Lack of Effect of MICA Antibodies on Graft Survival Following Heart Transplantation by Smith, J. D., Brunner, V. M., Jigjidsuren, S., Hamour, I. M., McCormack, A. M., Banner, N. R., Rose, M. L.

    Published in American journal of transplantation (01-08-2009)
    “…Little is known about the effect of MICA antibodies (Abs) on cardiac allograft function and survival. Pretransplant and posttransplant serum from 491 and 196…”
    Get full text
    Journal Article
  4. 4

    Current outcome of heart transplantation: a 10-year single centre perspective and review by HAMOUR, I. M, KHAGHANI, A, KANAGALA, P. K, MITCHELL, A. G, BANNER, N. R

    Published in QJM : An International Journal of Medicine (01-04-2011)
    “…Heart transplantation (HTx), the gold standard therapy for advanced heart failure, is limited by donor availability; alternative therapies are now becoming…”
    Get full text
    Journal Article
  5. 5

    Heart Transplantation for Homozygous Familial Transthyretin (TTR) V122I Cardiac Amyloidosis by Hamour, I. M., Lachmann, H. J., Goodman, H. J. B., Petrou, M., Burke, M. M., Hawkins, P. N., Banner, N. R.

    Published in American journal of transplantation (01-05-2008)
    “…Heart failure is the usual cause of death in patients with amyloid cardiomyopathy. The commonest form of hereditary cardiac amyloidosis is associated with the…”
    Get full text
    Journal Article
  6. 6

    Chronic kidney disease after heart transplantation by Hamour, Iman M., Omar, Fazir, Lyster, Haifa S., Palmer, Andrew, Banner, Nicholas R.

    Published in Nephrology, dialysis, transplantation (01-05-2009)
    “…Background. Chronic kidney disease (CKD) is a complication of heart transplantation related to calcineurin inhibitor nephrotoxicity. However, it is unclear…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Impaired Left Ventricular Systolic Function Early After Heart Transplantation is Associated with Cardiac Allograft Vasculopathy by Bolad, I.A., Robinson, D. R., Webb, C., Hamour, I., Burke, M.M., Banner, N.R.

    Published in American journal of transplantation (01-01-2006)
    “…Cardiac allograft vasculopathy (CAV) is a major cause of death more than 1 year after heart transplantation. We evaluated the role and possible predictive…”
    Get full text
    Journal Article
  9. 9

    Early impact of COVID-19 pandemic on heart transplant volumes in Asia and Oceania: results from the Global Observatory on Donation and Transplantation (GODT) by Manla, Y, Bader, N, Bajwa, G, Gobolos, L, Alsindi, F, Hamour, I, Ghalib, H, Al Badarin, F

    Published in European heart journal (04-02-2022)
    “…Abstract Funding Acknowledgements Type of funding sources: None. Introduction Massive demand for healthcare services worldwide following the emergence of…”
    Get full text
    Journal Article
  10. 10

    Association of Multidisciplinary Heart Failure Team with Outcomes in Patients Requiring Extracorporeal Membrane Oxygenation by Gabra, G., Hamour, I., Soliman, M., El Tahlawy, W., Manla, Y., Al Badarin, F., Bajwa, G., Alsindi, F., Ghalib, H., Ferrer, R., Kakar, V., Bader, F.

    “…Veno-arterial (VA) ECMO plays a central role in patients with refractory cardiogenic shock. Whether involvement of a multidisciplinary heart failure team…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Limited utility of endomyocardial biopsy in the first year after heart transplantation by Hamour, Iman M, Burke, Margaret M, Bell, Alex D, Panicker, Mathen G, Banerjee, Rajasi, Banner, Nicholas R

    Published in Transplantation (15-04-2008)
    “…Surveillance endomyocardial biopsies (EMBs) are used for the early diagnosis of acute cardiac allograft rejection. Protocols became standardized in an earlier…”
    Get full text
    Journal Article
  15. 15

    Transfer from ciclosporin to mycophenolate-sirolimus immunosuppression for chronic renal disease after heart transplantation: safety and efficacy of two regimens by Lyster, Haifa, Leaver, Neil, Hamour, Iman, Palmer, Andy, Banner, Nicholas R.

    Published in Nephrology, dialysis, transplantation (01-12-2009)
    “…Background. Chronic kidney disease is common after heart transplantation, and is related to ciclosporin (CsA) therapy. We compared the safety and efficacy of…”
    Get full text
    Journal Article
  16. 16

    A Reevaluation of the Role of IgM Non-HLA Antibodies in Cardiac Transplantation by SMITH, John D, HAMOUR, Iman M, ROSE, Marlene L, BURKE, Margaret M, MAHESH, Balikrishnan, STANFORD, Rachel E, HAJ-YAHIA, Saleem, ROBINSON, Derek R, KAUL, Pradeep, YACOUB, Magdi H, BANNER, Nicholas R

    Published in Transplantation (27-03-2009)
    “…Preexisting IgG antibodies to donor human leukocyte antigens (HLA) are a risk factor for rapid allograft rejection. However, non-HLA antibodies, of the IgM…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Reversible sirolimus-associated pneumonitis after heart transplantation by Hamour, Iman M, Mittal, Taurn K, Bell, Alex D, Banner, Nicholas R

    “…Sirolimus (rapamycin) and everolimus are immunosuppressive agents that inhibit cardiac allograft vasculopathy. Sirolimus has been widely used in renal…”
    Get more information
    Journal Article
  19. 19

    An innovative timestamp-based convolution integral method in synchrophasor estimation within digital relays by Zhiying Zhang, Korovin, O., Mutnuri, S., Hamour, I., Voloh, I., Lebo Jiang

    “…In recent years, phasor measurement units (PMU) and wide-area monitoring systems (WAMS) techniques have been widely used in power systems to perform various…”
    Get full text
    Conference Proceeding